India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Discover why Navin Fluorine International shares skyrocketed 22% in just three trading sessions. Expert analysis reveals the key drivers behind this chemical sector powerhouse's impressive rally and what investors should watch next.
Market eyes Wednesday's Q2 earnings bonanza as pharma giant Sun Pharma, Grasim Industries, and FMCG major Britannia declare results. Get complete analysis and investor expectations.
Religare Broking's Ajit Mishra reveals 3 promising stocks for short-term gains. Discover technical analysis and price targets for Grasim, Aurobindo Pharma, and City Union Bank in this exclusive market insight.
Get expert stock market insights from Jigar Patel of Anand Rathi as he reveals why Oil India, Aurobindo Pharma, and Latent View Analytics present compelling short-term opportunities for Indian investors.
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
A Bengaluru family's desperate act leaves two dead and two fighting for life after consuming poison, with police investigating massive real estate financial losses as the motive.
Food delivery giant Swiggy reports widening losses amid intense competition with Blinkit and Zepto. Company plans cash reserve boost for Instamart expansion in quick commerce showdown.
Swiggy's Q2 FY24 shows explosive 40% revenue growth to ₹2,730 crore, but net loss expands to ₹1,630 crore. Discover the 5 key factors every investor must know about the food delivery giant's financial health.
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
Federal health officials are accelerating efforts to bring cheaper biotech drugs to market, potentially transforming treatment access and creating new opportunities for Indian pharmaceutical companies.
NMDC Steel shows impressive recovery with narrowed losses and significant production growth at Nagarnar plant. Read the complete financial analysis.
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Air India faces renewed financial turbulence as Pakistan's airspace closure forces longer routes, potentially derailing Tata Group's ambitious transformation strategy for the national carrier.
Major Indian IT firms and global corporations are quietly replacing white-collar roles with artificial intelligence, creating a silent crisis in sectors once considered safe from automation.
Indian aviation sector heads for turbulent times with projected massive losses in FY26 as ATF prices surge and passenger growth slows, putting airline margins under severe pressure.
Silicon Valley's biggest players are executing massive layoffs as artificial intelligence reshapes workforce needs. Discover how Amazon, Microsoft, Google, Meta, Intel, TCS and IBM are cutting over 80,000 positions in historic tech restructuring.
Amazon announces largest workforce reduction since 2022, cutting up to 30,000 positions across multiple departments starting this week in major cost-cutting move.
Unexpected heavy rainfall in Gujarat's key agricultural regions has devastated standing paddy crops, leaving farmers grappling with substantial financial losses and uncertain futures as harvest season approaches.
Heavy monsoon showers batter South Gujarat districts, leaving Valsad's paddy farmers staring at massive crop destruction and financial ruin as fields submerge.
Exclusive report reveals Himachal Pradesh suffered staggering financial losses from relentless natural disasters, with cloudbursts and floods causing unprecedented destruction across the mountain state.
American soybean farmer Scott Bessent sparks outrage with insensitive comments as US farmers suffer massive losses from China's trade boycott. Exclusive analysis of the agricultural trade crisis.
Shocking report exposes how Himachal Pradesh suffered catastrophic losses worth ₹46,000 crore due to natural disasters between 2020-2024, with climate change wreaking unprecedented havoc.